Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer
NCT07159204
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Biliary Tract Cancer (BTC)
Interventions
DRUG:
Paclitaxel polymer micelle immunocombination
Sponsor
Peking Union Medical College Hospital